Concepedia

Jens Schrezenmeier

JS

Statistics

Publications

6

Citations

261

H-Index

6

Active since

2017

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Heidelberg University

German Cancer Research Center

German Red Cross

University of Würzburg

Jens Schrezenmeier is an author at Charité - Universitätsmedizin Berlin specializing in medicine, sepsis, and atherosclerosis.

ORCID

Top concepts

Publications per year

2017–2025

6

Publications

6

Initiation of acute graft-versus-host disease by angiogenesis

Katarina Riesner, Yu Shi, Angela Jacobi et al. · Blood · 2017 · 67 citations · Full text

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel et al. · Nature Cancer · 2022 · 62 citations · Full text

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas

Maurice Reimann, Jens Schrezenmeier, Paulina Richter‐Pechańska et al. · Blood · 2020 · 58 citations

Endothelial damage and dysfunction in acute graft-versus-host disease

Steffen Cordes, Zeinab Mokhtari, Maria Bartosova et al. · Haematologica · 2020 · 47 citations · Full text

, , +19

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial

Simone Hoffmann, Eva Schrezenmeier, Maxime Desmarets et al. · EBioMedicine · 2025 · 16 citations · Full text

1–5 of 6